Considering that amplification and mutations of PIK3CA is a common event in human tumors, and PIK3CA mutations and/or PTEN loss cooperates with TP53 mutation to drive the development of bladder cancer (71). The gene discussed is TP53; the disease is urinary bladder carcinoma.